AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,175.00GBp
12:14pm EDT
Price Change (% chg)

132.50p (+3.28%)
Prev Close
4,042.50p
Open
4,010.00p
Day's High
4,296.50p
Day's Low
4,008.50p
Volume
5,270,912
Avg. Vol
2,715,269
52-wk High
4,296.50p
52-wk Low
3,028.50p

AZN.L

Chart for AZN.L

About

AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments... (more)

Overall

Beta: 0.34
Market Cap (Mil.): £51,115.67
Shares Outstanding (Mil.): 1,261.30
Dividend: 116.80
Yield (%): 4.36

Financials

  AZN.L Industry Sector
P/E (TTM): 33.32 33.36 33.52
EPS (TTM): 1.22 -- --
ROI: 6.49 19.69 18.94
ROE: 10.89 20.38 19.71
Search Stocks

Deals of the day- Mergers and acquisitions

(Adds Neovia Logistics, Elizabeth Arden, Ellaktor, ConAgra Foods, Facebook, NTT DoCoMo, Pioneers Holding)

4:10pm EDT

Zimmer to buy Biomet for $13.35 billion in latest consolidation

- Zimmer Holdings Inc said on Thursday it would buy rival orthopedic products maker Biomet Inc for more than $13 billion, the latest deal in a wave of consolidations in the healthcare industry.

1:43pm EDT

UPDATE 3-AstraZeneca plans spin-offs as cancer progress fuels bid talk

* Anti-PD-L1 product and three other drugs into Phase III

8:16am EDT

Drugmaker AstraZeneca drives FTSE to multi-week high

* FTSE 100 index rises 0.7 percent * Bid speculation boosts AstraZeneca * Analysts target further 1 pct gain on index By Tricia Wright LONDON, April 24 - Gains in AstraZeneca driven by bid speculation helped propel Britain's FTSE 100 to six-week highs on Thursday, with analysts seeing scope for more gains on the index after it moved above its recent range. AstraZeneca climbed 5.3 percent to a record high, extending this week's strong advance on Pfizer's reported i

7:52am EDT

US STOCKS-Futures gain on tech results, Apple soars in premarket

* Tech results lift Nasdaq futures, Apple and Facebook rally

7:39am EDT

Weaker FTSE 100 gets support from ABF and AstraZeneca

* ABF surges; Primark targets U.S. with first store openings

23 Apr 2014

Weaker FTSE 100 gets support from ABF and AstraZeneca

LONDON, April 23 - Strength in Associated British Foods on U.S. growth prospects and in drugmakers on expectations of sector consolidation kept Britain's top share index near a two-week high on Wednesday.

23 Apr 2014

Weaker FTSE 100 gets support from ABF and AstraZeneca

LONDON, April 23 - Strength in Associated British Foods on U.S. growth prospects and in drugmakers on sector consolidation expectations kept Britain's top share index near a two-week high on Wednesday.

23 Apr 2014

UK's FTSE propped up by ABF and AstraZeneca

LONDON, April 23 - A rise in the share prices of Associated British Foods and drugmaker AstraZeneca buoyed Britain's top equity index on Wednesday, leaving the market near a two-week high.

23 Apr 2014

Novartis and GSK trade assets as pharma industry reshapes

ZURICH/LONDON - Novartis and GlaxoSmithKline agreed to trade more than $20 billion worth of assets on Tuesday to bolster their best businesses and exit weaker ones as the drug industry contends with healthcare spending cuts and generic competition. | Video

22 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks